Approximately 25% of patients presenting with Paget's disease of bone have a low serum magnesium concentration (below 0·74 mmol/L), Metabolic balance studies of 12 normomagnesaemic and seven hypomagnesaemic subjects show that the latter have a significantly more positive balance and a significantly higher net absorption of magnesium than have the former. The urinary output of the two groups did not differ significantly. The serum magnesium and alkaline phosphatase (log) concentrations were significantly negatively correlated, as were the serum magnesium and the daily urinary hydroxyproline (log) output. Low serum magnesium concentrations are thus associated with highly active Paget's disease; they do not arise from increased urinary loss nor from a lowered net absorption of magnesium, but probably from increased uptake by bone. The balance data show that to avoid a negative magnesium balance, the magnesium intake in Paget's disease should be at least 8·0 mmol/day.
There are few accounts of the serum magnesium concentration in Paget's disease of bone, and following the observations of Avioli and Berman! the concentration is considered/ to be within the reference range for normal adults which in the author's laboratory is 0·74 to 1·00 mrnol/L, During studies of magnesium metabolism in Paget's disease from 1965 to 1970, it was noticed that several patients had serum concentrations below O· 74 rnrnol/L and this observation was confirmed during further metabolic studies in 1983. The two sets of data have been combined and are presented below. An account of the early observations was given first in 1982 at the Association of Clinical Biochemists training course at Manchester, and of the combined data at the First European Congress on Magnesium in 1983. 3 
Patients
The diagnosis of Paget's disease was made on clinical and radiological evidence by a consultant clinician and a radiologist, with a raised plasma alkaline phosphatase in all but four normomagnesaemic patients and raised urinary hydroxyproline excretion in all but four patients in whom the investigation was carried out. The upper normal limit for plasma alkaline phosphatase was 13·5 King-Armstrong units/l00 rnl., and for urinary hydroxyproline 270 umol/ day. All patients have been followed for 1-20 years and the diagnosis has not been changed in any. None of the patients had renal disease, and patients taking diuretics were excluded.
Each patient's dietary history was taken on admission. Each was then balanced on a calcium, phosphate, magnesium and calorie intake which the history indicated was normal for each individual.
Methods
Serum and urinary magnesium were determined by conventional atomic absorption spectrometry using the SP 1900 (Pye-Unicam, Cambridge, UK). Faecal and food magnesium were initially determined by atomic absorption spectrometry and in 1983 by DC plasma emission spectrometry usmg the Spectrospan III (Beckman-RIIC, High Wycombe, U.K.).
Balance studies, on a fixed diet, have been carried out in the Metabolic Wards of the Liverpool Royal Infirmary (1965 to 1970) and Royal Liverpool Hospital (1983). Stools were collected over periods of six days using, at first, conventional carmine markers and, since 1966, continuous chromium sesquioxide marking." Faecal chromium was, at first, determined according to Rose." and in 1983 by plasma emission spectrometry. 5 Patient preparation and stool collection have been described previously.f All patients were fasted overnight before venepuncture for serum magnesium assay. Faecal chromium recoveries were 100-106%.5 disease the 21 low or marginal values and the values of the 12 normomagnesaemic patients who had balances, are means of at least two determinations; the remaining 31 patients had mostly single determinations.
Results

Magnesium balance
In order to ascertain the metabolic factors causing the low serum magnesium levels a 6-day metabolic balance was carried out (Table I) in 19 patients (nine male, 10 female) seven of whom were hypomagnesaemic. Seven patients were considered, arbitrarily, to be in negative balance (more negative than -1·0 mmoVday) and one of these (No.2) had a low serum Mg 2 + .
Eight were in neutral balance (between ± 1·0 rnmol/day) of whom three (Nos 6, 7 and 17) had low serum Mg 2 + concentrations. Four were in positive balance including three (Nos 9, 18 and 19) with low serum Mg 2 + concentration. Low serum magnesium concentration was therefore not associated with a negative magnesium balance, as might have been expected, but rather with neutral or positive balance. Table 2 shows that the mean magnesium balance of +0·69 mmoVday in the hypomagnesaemic patients was significantly higher than that of -1·20 mmoVday in the normomagnesaemic group (P<0·05).
The mean urinary magnesium output of the two groups ( Table 2 ) was virtually identical, so that the higher positive magnesium balance of the hypomagnesaemic patients arose from a significantly increased net absorption of magnesium (Table 2) (P<0·05). The hypomagnesaemic patients had a higher mean intake of magnesium than had the normomagnesaemic patients, but this difference was not of statistical significance. Figure 2 shows that the serum magnesium and the (log) plasma alkaline phosphatase concentrations were weakly but significantly negatively correlated (n=61, r= -0·340, 0·01> P> 0,001). 
C"l
Serum magnesium
Of 64 patients (24 male, 40 female) with Paget's disease of bone, 17 (26'6%) six male, 11 female) had a serum magnesium concentration below 0·74 mmol/L, Figure 1 "The net absorption of magnesium and the magnesium balance, in patients with a low serum magnesium concentration, are significantly greater than in those with normal serum levels (0,05> P> 0·25). also significantly negatively correlated (n=45, r=-0·394, 0·01> P> 0.(01) (Fig. 3 ).
Discussion
The results show that approximately a quarter of all patients with Paget's disease present with a low serum magnesium and that such patients tend to have relatively active disease, as measured by raised levels of serum alkaline phosphatase and urinary hydroxyproline. The low serum magnesium does not arise from increased urinary loss of magnesium and the patients, as a group, have a significantly increased absorption of magnesium with a significantly more positive magnesium balance than their normomagnesaemic counterparts. One must conclude, therefore, that magnesium is being retained within cells or within bone. Since the serum magnesium is lower the more active the disease it is tempting to think that magnesium is required in increased amounts in the diseased areas where there are high rates of bone accretion and destruction with increased numbers of osteoclasts and osteoblasts. In active Paget's disease, bone mass increases and a need for magnesium may arise for this reason alone. Additionally magnesium is a well-known activator of alkaline phosphatase and it may be that the magnesium ion is sequestered on to the enzyme molecule. The enzyme also contains zinc within its molecular structure and such a hypothesis would be strengthened if serum zinc was also found to be lowered in Paget's disease. This possibility is being investigated. The present observations, whatever their (Table 1) indicate that to avoid a negative magnesium balance (more negative than 1 mmollday), the magnesium intake in Paget's disease should be at least g·Ommol/day, and it is now our practice to provide 10-12 mmollday for our patients by a suitable choice of foods, as inorganic magnesium salts by mouth tend to increase stool frequency. The balance studies have been used in this investigation principally to elucidate the metabolic factors causing low serum magnesium levels. The data may also constitute the largest number of magnesium balance studies yet published on Paget's disease and have an interest of their own. The mean balance of -0·09±1·98 mmollday indicates that, overall, the group of patients was in neutral balance, but the data hide quite wide differences ranging from -4·24 to +2·38 mmollday in individual patients, each of whom requires therapy individually, depending not only on the Low serum Mg in osteitis deformans 595 balance, but also upon the level of the serum magnesium.
